Hemorrhagic Kaposi sarcoma. Successful treatment with IFN-alpha

Eur J Dermatol. 2004 Jan-Feb;14(1):37-40.

Abstract

A 76-year-old woman with atypical hemorrhagic Kaposi sarcoma is presented. The patient was treated with recombinant interferon alpha-2b (3,000,000 IU) subcutaneously, three times weekly for 6 months and twice weekly as maintenance dose for 14 months with excellent response and no recurrence after a 7 years of follow-up.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Biopsy, Needle
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Follow-Up Studies
  • Hemorrhage / drug therapy
  • Hemorrhage / pathology
  • Humans
  • Immunohistochemistry
  • Injections, Subcutaneous
  • Interferon alpha-2
  • Interferon-alpha / administration & dosage*
  • Recombinant Proteins
  • Risk Assessment
  • Sarcoma, Kaposi / drug therapy*
  • Sarcoma, Kaposi / pathology*
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / pathology*
  • Treatment Outcome

Substances

  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins